227 related articles for article (PubMed ID: 25887042)
1. Stereotactic body radiotherapy for Stage I lung cancer with chronic obstructive pulmonary disease: special reference to survival and radiation-induced pneumonitis.
Inoue T; Shiomi H; Oh RJ
J Radiat Res; 2015 Jul; 56(4):727-34. PubMed ID: 25887042
[TBL] [Abstract][Full Text] [Related]
2. Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy.
Takeda A; Kunieda E; Ohashi T; Aoki Y; Oku Y; Enomoto T; Nomura K; Sugiura M
Chest; 2012 Apr; 141(4):858-866. PubMed ID: 21885726
[TBL] [Abstract][Full Text] [Related]
3. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review.
Palma D; Lagerwaard F; Rodrigues G; Haasbeek C; Senan S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1149-56. PubMed ID: 21640513
[TBL] [Abstract][Full Text] [Related]
4. Hyperpolarized (3)He pulmonary functional magnetic resonance imaging prior to radiation therapy.
Mathew L; Vandyk J; Etemad-Rezai R; Rodrigues G; Parraga G
Med Phys; 2012 Jul; 39(7):4284-90. PubMed ID: 22830762
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy.
Hara Y; Takeda A; Eriguchi T; Sanuki N; Aoki Y; Nishimura S; Enomoto T; Shinkai M; Kawana A; Kaneko T
J Radiat Res; 2016 Jan; 57(1):62-7. PubMed ID: 26487713
[TBL] [Abstract][Full Text] [Related]
6. Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis.
Aibe N; Yamazaki H; Nakamura S; Tsubokura T; Kobayashi K; Kodani N; Nishimura T; Okabe H; Yamada K
J Radiat Res; 2014 May; 55(3):575-82. PubMed ID: 24457315
[TBL] [Abstract][Full Text] [Related]
7. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection.
Sekine Y; Suzuki H; Yamada Y; Koh E; Yoshino I
Thorac Cardiovasc Surg; 2013 Mar; 61(2):124-30. PubMed ID: 22535670
[TBL] [Abstract][Full Text] [Related]
8. Reassessment of declines in pulmonary function ≥1 year after stereotactic body radiotherapy.
Takeda A; Enomoto T; Sanuki N; Handa H; Aoki Y; Oku Y; Kunieda E
Chest; 2013 Jan; 143(1):130-137. PubMed ID: 22722234
[TBL] [Abstract][Full Text] [Related]
9. Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer.
Jeppesen SS; Hansen NG; Schytte T; Nielsen M; Hansen O
Lung Cancer; 2016 Oct; 100():90-95. PubMed ID: 27597286
[TBL] [Abstract][Full Text] [Related]
10. Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non-small-cell lung cancer.
Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
Int J Chron Obstruct Pulmon Dis; 2016; 11():43-9. PubMed ID: 26766906
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm.
Takeda A; Sanuki N; Kunieda E; Ohashi T; Oku Y; Takeda T; Shigematsu N; Kubo A
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):442-8. PubMed ID: 18990507
[TBL] [Abstract][Full Text] [Related]
12. [Impact of Chronic Obstructive Pulmonary Disease on Risk of Recurrence in Patients with Resected Non-small Cell Lung Cancer].
Qiang G; Yu Q; Liang C; Song Z; Shi B; Guo Y; Liu D
Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):215-220. PubMed ID: 29587946
[TBL] [Abstract][Full Text] [Related]
13. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Shaverdian N; Veruttipong D; Wang J; Schaue D; Kupelian P; Lee P
Clin Lung Cancer; 2016 Jan; 17(1):39-46. PubMed ID: 26372098
[TBL] [Abstract][Full Text] [Related]
15. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer.
Ueki N; Matsuo Y; Togashi Y; Kubo T; Shibuya K; Iizuka Y; Mizowaki T; Togashi K; Mishima M; Hiraoka M
J Thorac Oncol; 2015 Jan; 10(1):116-25. PubMed ID: 25376512
[TBL] [Abstract][Full Text] [Related]
16. Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer.
Onishi H; Marino K; Yamashita H; Terahara A; Onimaru R; Kokubo M; Shioyama Y; Kozuka T; Matsuo Y; Aruga T; Hiraoka M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818801323. PubMed ID: 30286697
[TBL] [Abstract][Full Text] [Related]
17. Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection.
Hayes JT; David EA; Qi L; Chen AM; Daly ME
Clin Lung Cancer; 2015 Sep; 16(5):379-84. PubMed ID: 25737143
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review.
Doi H; Nakamatsu K; Nishimura Y
Int J Clin Oncol; 2019 Aug; 24(8):899-909. PubMed ID: 30937620
[TBL] [Abstract][Full Text] [Related]
19. Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease.
Bugge A; Lund MB; Brunborg C; Solberg S; Kongerud J
Ann Thorac Surg; 2016 Jun; 101(6):2125-31. PubMed ID: 27016839
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.
Baumann P; Nyman J; Hoyer M; Gagliardi G; Lax I; Wennberg B; Drugge N; Ekberg L; Friesland S; Johansson KA; Lund JS; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R
Radiother Oncol; 2008 Sep; 88(3):359-67. PubMed ID: 18768228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
